Vaccinex, Inc.
VCNX· OTC
VCNXVaccinex, Inc.
Filed Mar 13, 2019 · 10-K · 72 days after period end · 0001564590-19-007458
derived · Computed from the longer spans the company filed.
| Metric | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures |
|---|---|---|
| Revenue | $194.00K | — |
| Net Income | -$8.45M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaccinex, Inc. · CIK 1205922 · Engraved from SEC EDGAR
ended Dec 31, 2018 · filed Mar 13, 2019 · 72 d after period end
